271 related articles for article (PubMed ID: 26921376)
1. Cardiac Resynchronization Therapy: US Trends and Disparities in Utilization and Outcomes.
Sridhar AR; Yarlagadda V; Parasa S; Reddy YM; Patel D; Lakkireddy D; Wilkoff BL; Dawn B
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003108. PubMed ID: 26921376
[TBL] [Abstract][Full Text] [Related]
2. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
Kramer DB; Normand ST; Volya R; Hatfield LA
Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
[TBL] [Abstract][Full Text] [Related]
3. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States.
Patel N; Viles-Gonzalez J; Agnihotri K; Arora S; Patel NJ; Aneja E; Shah M; Badheka AO; Pothineni NV; Kancharla K; Mulpuru S; Noseworthy PA; Kusumoto F; Cha YM; Deshmukh AJ
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1425-1435. PubMed ID: 30016005
[TBL] [Abstract][Full Text] [Related]
4. The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France.
Galand V; Linde C; Lellouche N; Mansourati J; Deharo JC; Sagnol P; Da Costa A; Horvilleur J; Defaye P; Boveda S; Steinbach M; Bru P; Rumeau P; Beard T; Younsi S; Dickstein K; Normand C; Leclercq C
Arch Cardiovasc Dis; 2019 Nov; 112(11):713-722. PubMed ID: 31706879
[TBL] [Abstract][Full Text] [Related]
5. Variation in critical care unit admission rates and outcomes for patients with acute coronary syndromes or heart failure among high- and low-volume cardiac hospitals.
van Diepen S; Bakal JA; Lin M; Kaul P; McAlister FA; Ezekowitz JA
J Am Heart Assoc; 2015 Feb; 4(3):e001708. PubMed ID: 25725089
[TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy: implant rates, temporal trends and relationships with heart failure epidemiology.
Boriani G; Berti E; Belotti LM; Biffi M; Carboni A; Bandini A; Casali E; Tomasi C; Toselli T; Baraldi P; Bottoni N; Barbato G; Sassone B;
J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):147-54. PubMed ID: 23811841
[TBL] [Abstract][Full Text] [Related]
7. Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.
Hosseini SM; Moazzami K; Rozen G; Vaid J; Saleh A; Heist KE; Vangel M; Ruskin JN
Eur Heart J; 2017 Jul; 38(27):2122-2128. PubMed ID: 28329322
[TBL] [Abstract][Full Text] [Related]
8. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study.
Sridhar AR; Yarlagadda V; Yeruva MR; Kanmanthareddy A; Vallakati A; Dawn B; Lakkireddy D
Europace; 2015 Oct; 17(10):1548-54. PubMed ID: 25855676
[TBL] [Abstract][Full Text] [Related]
9. Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients.
Farmer SA; Tuohy EJ; Small DS; Wang Y; Groeneveld PW
Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):798-807. PubMed ID: 23093561
[TBL] [Abstract][Full Text] [Related]
10. Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases.
Banks H; Torbica A; Valzania C; Varabyova Y; Prevolnik Rupel V; Taylor RS; Hunger T; Walker S; Boriani G; Fattore G;
Europace; 2018 Apr; 20(4):643-653. PubMed ID: 29016747
[TBL] [Abstract][Full Text] [Related]
11. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
[TBL] [Abstract][Full Text] [Related]
12. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy.
Aktas MK; Zareba W; Huang DT; McNitt S; Polonsky S; Chen L; Stockburger M; Merkely B; Moss AJ; Kutyifa V
J Card Fail; 2014 Mar; 20(3):183-9. PubMed ID: 24361804
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
[TBL] [Abstract][Full Text] [Related]
14. Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter-Defibrillator (ICD) Utilization: A United States Experience Over the Last Decade.
Patel NJ; Edla S; Deshmukh A; Nalluri N; Patel N; Agnihotri K; Patel A; Savani C; Patel N; Bhimani R; Thakkar B; Arora S; Asti D; Badheka AO; Parikh V; Mitrani RD; Noseworthy P; Paydak H; Viles-Gonzalez J; Friedman PA; Kowalski M
Clin Cardiol; 2016 Feb; 39(2):63-71. PubMed ID: 26799597
[TBL] [Abstract][Full Text] [Related]
15. Second European Society of Cardiology Cardiac Resynchronization Therapy Survey: the Italian cohort.
Botto GL; Gasparini M; Brasca FMA; Casale MC; Occhetta E; Racheli M; Bertaglia M; Zanon F; Zardini M; Rapacciuolo A; Mascioli G; Curnis A; Metra M; Normand C; Dickstein K; Linde C
J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):634-640. PubMed ID: 32740496
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardiac device procedures in older patients: use and in-hospital outcomes.
Swindle JP; Rich MW; McCann P; Burroughs TE; Hauptman PJ
Arch Intern Med; 2010 Apr; 170(7):631-7. PubMed ID: 20386008
[TBL] [Abstract][Full Text] [Related]
17. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.
Cheung JW; Ip JE; Markowitz SM; Liu CF; Thomas G; Feldman DN; Swaminathan RV; Lerman BB; Kim LK
Heart Rhythm; 2017 Jul; 14(7):1043-1050. PubMed ID: 28214565
[TBL] [Abstract][Full Text] [Related]
18. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
[TBL] [Abstract][Full Text] [Related]
19. Safety and Cost-Effectiveness of Same-Day Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Implantation.
Atherton G; McAloon CJ; Chohan B; Heining D; Anderson B; Barker J; Randeva H; Osman F
Am J Cardiol; 2016 May; 117(9):1488-93. PubMed ID: 26993428
[TBL] [Abstract][Full Text] [Related]
20. Universal Health Insurance Coverage in Massachusetts Did Not Change the Trajectory of Arthroplasty Use or Costs.
Kurtz SM; Lau E; Ong KL; Katz JN; Bozic KJ
Clin Orthop Relat Res; 2016 May; 474(5):1090-8. PubMed ID: 26683036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
